CRP
Decrease · moderate
Anti-inflammatory signaling
Literature evidence
Compound library
Vivy evidence dossier
Fisetin
Also indexed as Fisetin, 3,7,3',4'-Tetrahydroxyflavone
T2Supplements
Read this entry as context, not instruction.
Evidence labels describe the material available in this reference entry. They do not establish that a compound is appropriate, effective, or safe for you. Inclusion is not a recommendation to use it.
Reference context
Pharmacokinetic context
Half-life3.0 days
This field summarizes the library record. Half-life can vary with formulation, indication, and individual clinical context.
Observed relationships
Biomarker context
IL-6
Decrease · small
Cytokine modulation
Literature evidence
TNF-alpha
Decrease · small
Cytokine modulation
Literature evidence
Oxidative stress
Decrease · moderate
Antioxidant effects
Literature evidence
Keep in view
Safety discussion points
Fisetin is a flavonol senolytic compound that may selectively eliminate senescent cells. Investigational for aging and age-related diseases.
Keep the reference close
Track Fisetin in context.
Hey Vivy helps you organize protocols and review change over time. It does not diagnose, prescribe, or replace qualified care.